|
[1]KUNTZEN C, SCHWABE RF.Gut microbiota and Toll-like receptors set the stage for cytokine-mediated failure of antibacterial responses in the fibrotic liver[J].GUT, 2017, 66 (3) :396-398.
|
|
[2]XIE G, ZHONG W, ZHENG X, et al.Chronic ethanol consumption alters mammalian gastrointestinal content metabolites[J].J Proteome Res, 2013, 12 (7) :3297-3306.
|
|
[3]ENGEN PA, GREEN SJ, VOIGT RM, et al.The Gastrointestinal Microbiome:Alcohol Effects on the Composition of Intestinal Microbiota[J].Alcohol Res, 2015, 37 (2) :223-236.
|
|
[4]BULL-OTTERSON L, FENG W, KIRPICH I, et al.Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment[J].PLo S One, 2013, 8 (1) :e53028.
|
|
[5]MUTLU EA, GILLEVET PM, RANGWALA H, et al.Colonic microbiome is altered in alcoholism[J].Am J Physiol Gastrointest Liver Physiol, 2012, 302 (9) :g966-g978.
|
|
[6]MASLOWSKI KM, VIEIRA AT, NG A, et al.Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43[J].Nature, 2009, 461 (7268) :1282-1286.
|
|
[7]KIM MH, KANG SG, PARK JH, et al.Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice[J].Gastroenterology, 2013, 145 (2) :396-406.
|
|
[8]COTILLARD A, KENNEDY SP, KONG LC, et al.Dietary intervention impact on gut microbial gene richness[J].Nature, 2013, 500 (7464) :585-588.
|
|
[9] QIN N, YANG F, LI A, et al.Alterations of the human gut microbiome in liver cirrhosis[J].Nature, 2014, 513 (7516) :59-64.
|
|
[10]COUCH RD, DAILEY A, ZAIDI F, et al.Alcohol induced alterations to the human fecal VOC metabolome[J].PLo S One, 2015, 10 (3) :e119362.
|
|
[11]DUNAGAN M, CHAUDHRY K, SAMAK G, et al.Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism[J].Am J Physiol Gastrointest Liver Physiol, 2012, 303 (12) :g1356-g1364.
|
|
[12]WANG Y, TONG J, CHANG B, et al.Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junctionassociated proteins[J].Mol Med Rep, 2014, 9 (6) :2352-2356.
|
|
[13]DAVID BA, REZENDE RM, ANTUNES MM, et al.Combination of mass cytometry and imaging analysis reveals origin, location, and functional repopulation of liver myeloid cells in mice[J].Gastroenterology, 2016, 151 (6) :1176-1191.
|
|
[14]SZABO G.Gut-liver axis in alcoholic liver disease[J].Gastroenterology, 2015, 148 (1) :30-36.
|
|
[15]ROH YS, ZHANG B, LOOMBA R, et al.TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1and neutrophil infiltration[J].Am J Physiol Gastrointest Liver Physiol, 2015, 309 (1) :g30-g41.
|
|
[16]WANG Y, LIU Y, KIRPICH I, et al.Lactobacillus rhamnosus GG reduces hepatic TNFalpha production and inflammation in chronic alcohol-induced liver injury[J].J Nutr Biochem, 2013, 24 (9) :1609-1615.
|
|
[17]SZABO G, PETRASEK J.Gut-liver axis and sterile signals in the development of alcoholic liver disease[J].Alcohol Alcohol, 2017, 52 (4) :414-424.
|
|
[18]BASHIARDES S, SHAPIRO H, ROZIN S, et al.Non-alcoholic fatty liver and the gut microbiota[J].Mol Metab, 2016, 5 (9) :782-794.
|
|
[19]BACKHED F, MANCHESTER JK, SEMENKOVICH CF, et al.Mechanisms underlying the resistance to diet-induced obesity in germ-free mice[J].Proc Natl Acad Sci U S A, 2007, 104 (3) :979-984.
|
|
[20]MIURA K, OHNISHI H.Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease[J].World J Gastroenterol, 2014, 20 (23) :7381-7391.
|
|
[21]NAKAMOTO N, KANAI T.Role of toll-like receptors in immune activation and tolerance in the liver[J].Frontiers in Immunology, 2014, 5:221.
|
|
[22]DIXON LJ, BERK M, THAPALIYA S, et al.Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis[J].Lab Invest, 2012, 92 (5) :713-723.
|
|
[23]YANG G, LEE HE, LEE JY.A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet[J].Sci Rep, 2016, 6:24399.
|
|
[24]BACH KK.Microbial degradation of whole-grain complex carbohydrates and impact on short-chain fatty acids and health[J].Adv Nutr, 2015, 6 (2) :206-213.
|
|
[25]KIMURA I, OZAWA K, INOUE D, et al.The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43[J].Nat Commun, 2013, 4:1829.
|
|
[26]SAYIN SI, WAHLSTROM A, FELIN J, et al.Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist[J].Cell Metab, 2013, 17 (2) :225-235.
|
|
[27]de AGUIAR VT, TARLING EJ, EDWARDS PA.Pleiotropic roles of bile acids in metabolism[J].Cell Metab, 2013, 17 (5) :657-669.
|
|
[28]CIPRIANI S, MENCARELLI A, PALLADINO G, et al.FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats[J].J Lipid Res, 2010, 51 (4) :771-784.
|
|
[29]MOREAU R, JALAN R, GINES P, et al.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J].Gastroenterology, 2013, 144 (7) :1426-1437.
|
|
[30]BAJAJ JS, O'LEARY JG, REDDY KR, et al.Second infections independently increase mortality in hospitalized patients with cirrhosis:the North American consortium for the study of end-stage liver disease (NACSELD) experience[J].Hepatology, 2012, 56 (6) :2328-2335.
|
|
[31]BAJAJ JS, HEUMAN DM, HYLEMON PB, et al.Altered profile of human gut microbiome is associated with cirrhosis and its complications[J].J Hepatol, 2014, 60 (5) :940-947.
|
|
[32]CHEN Y, GUO J, QIAN G, et al.Gut dysbiosis in acute-onchronic liver failure and its predictive value for mortality[J].J Gastroenterol Hepatol, 2015, 30 (9) :1429-1437.
|
|
[33]YU LX, SCHWABE RF.The gut microbiome and liver cancer:mechanisms and clinical translation[J].Nat Rev Gastroenterol Hepatol, 2017, 14 (9) :527-539.
|
|
[34]EL-SERAG HB.Hepatocellular carcinoma[J].N Engl J Med, 2011, 365 (12) :1118-1127.
|
|
[35]SINGAL AG, EL-SERAG HB.Hepatocellular carcinoma from epidemiology to prevention:translating knowledge into practice[J].Clin Gastroenterol Hepatol, 2015, 13 (12) :2140-2151.
|
|
[36]HAN ML, GONG ZH.Mechanism of action of gut microbiota in hepatobiliary diseases[J].J Clin Hepatol, 2017, 33 (2) :384-388. (in Chinese) 韩美林, 龚振华.肠道菌群在肝胆疾病中的作用机制[J].临床肝胆病杂志, 2017, 33 (2) :384-388.
|
|
[37]PRADERE JP, TROEGER JS, DAPITO DH, et al.Toll-like receptor 4 and hepatic fibrogenesis[J].Semin Liver Dis, 2010, 30 (3) :232-244.
|
|
[38]BAJAJ JS, BETRAPALLY NS, GILLEVET PM.Decompensated cirrhosis and microbiome interpretation[J].Nature, 2015, 525 (7569) :e1-e2.
|
|
[39]QIN N, YANG F, LI A, et al.Alterations of the human gut microbiome in liver cirrhosis[J].Nature, 2014, 513 (7516) :59-64.
|
|
[40]VILSTRUP H, AMODIO P, BAJAJ J, et al.Hepatic encephalopathy in chronic liver disease:2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver[J].Hepatology, 2014, 60 (2) :715-735.
|
|
[41] LACHAR J, BAJAJ JS.Changes in the microbiome in cirrhosis and relationship to complications:hepatic encephalopathy, spontaneous bacterial peritonitis, and sepsis[J].Semin Liver Dis, 2016, 36 (4) :327-330.
|
|
[42]KANG DJ, BETRAPALLY NS, GHOSH SA, et al.Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice[J].Hepatology, 2016, 64 (4) :1232-1248.
|
|
[43]BAJAJ JS, BETRAPALLY NS, HYLEMON PB, et al.Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy[J].Hepatology, 2015, 62 (4) :1260-1271.
|
|
[44]KHANNA S, TOSH PK.A clinician's primer on the role of the microbiome in human health and disease[J].Mayo Clin Proc, 2014, 89 (1) :107-114.
|
|
[45]WANG GY, WANG GC.Reasearch progress of associated susceptible factors of spontaneous bacterial peritonitis in hepatic cirrhosis[J/CD].Chin J Liver Dis:Electronic Edition, 2016, 8 (2) :5-8. (in Chinese) 王贵云, 王拱辰.肝硬化并发自发性腹膜炎相关易感因素的研究进展[J/CD].中国肝脏病杂志:电子版, 2016, 8 (2) :5-8.
|
|
[46]LU L.Risk factors of liver cirrhosis ascites complicated with spontaneous bacterial peritonitis[J].China Med Herald, 2016, 13 (8) :140-142. (in Chinese) 陆琳.肝硬化腹水并发自发性腹膜炎的危险因素[J].中国医药导报, 2016, 13 (8) :140-142.
|
|
[47]LACHAR J, BAJAJ JS.Changes in the microbiome in cirrhosis and relationship to complications:hepatic encephalopathy, spontaneous bacterial peritonitis, and sepsis[J].Semin Liver Dis, 2016, 36 (4) :327-330.
|
|
[48]TUOMISTO S, PESSI T, COLLIN P, et al.Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics[J].BMC Gastroenterol, 2014, 14:40.
|
|
[49]SANTIAGO A, POZUELO M, POCA M, et al.Alteration of the serum microbiome composition in cirrhotic patients with ascites[J].Sci Rep, 2016, 6:25001.
|
|
[50]LUAN YT, CAI WJ, XU Y, et al.Role of intestinal flora in the development and progression of spontaneous bacterial peritonitis[J].J Clin Hepatol, 2016, 32 (8) :1622-1625. (in Chinese) 栾雨婷, 蔡文君, 徐莹, 等.肠道菌群在自发性细菌性腹膜炎发生发展中的作用[J].临床肝胆病杂志, 2016, 32 (8) :1622-1625.
|
|
[51]CHANDER RB, GARCIA-TSAO G, CIARLEGLIO MM, et al.Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls[J].J Clin Gastroenterol, 2013, 47 (10) :888-893.
|
DownLoad: